Post Market Clinical Study to Evaluate the Performance of the Versius Surgical System
CMR Surgical Ltd · NCT07096856
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 22+ · All sexes
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Not applicable
- Target enrollment
- 100
- US sites recruiting
- 2
- Study start
- March 23, 2026
- Record last updated
- September 11, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this clinical trial is to learn how the Versius Surgical System, a robotic surgery device, works for gallbladder removal surgery (cholecystectomy) in adults. The main questions it aims to answer are:
How often can the surgery be successfully completed using Versius without needing to switch to a different surgical method?
What serious complications, if any, occur within 30 days after surgery?
Researchers will collect information from adult patients who have gallbladder surgery using the Versius system in U.S. hospitals. The purpose is to better understand how the device performs and how patients recover after surgery.
Participants will
Be adults age 22 or older who are eligible for minimally invasive gallbladder surgery
Undergo robotic-assisted surgery using the Versius Surgical System
Allow the research team to collect data during surgery and up to 30 days after
Complete standard follow-up visits after discharge
Patients with certain medical conditions, such as cancer, high BMI (≥40 kg/m²), or contraindications to anesthesia or robotic surgery, will not be included in the study.
This study is sponsored by CMR Surgical Ltd., the manufacturer of the Versius system.
Being studied: Robotic assisted cholecystectomy
Conditions: Cholecystectomy, Robotic
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- 1. Adult patients 22 years of age and older, eligible for soft tissue minimal access surgery, for cholecystectomy 2. Patients providing written informed consent to participate in the study
Exclusion Criteria
- Patient unwilling to provide informed consent
- Patients undergoing surgery or treatment for malignant disease
- Patients undergoing a concomitant surgical procedure
- Medical contraindication for general anaesthesia or minimally invasive procedure
- Contraindication for undergoing surgery with Versius (Bleeding diathesis, Active pregnancy or BMI ≥40 kg/m2)
Recruiting US locations
Cedar-Sinai Heatlh Sciences University
Los Angeles, CA 90048
Site contact: Miguel Burch · 310-423-8350 · Miguel.Burch@csmc.edu
University of California San Diego Health
San Diego, CA 92037
Site contact: Ryan Broderick · 858-657-8860 · rbroderick@health.ucsd.edu
Study contacts (from the official record)
- Morad Nakleh · +44 7746008535 · morad.naklheh@cmrsurgical.com
- Martin Ramette · +447761631263 · martin.ramette@cmrsurgical.com